|
1.
|
|
|
Isotope release studies from nanostructured target materials
/ Berlin, Valentina (CERN, CH-1211 Geneva 23, Switzerland) ; Au, Mia (CERN, CH-1211 Geneva 23, Switzerland) ; Ajayakumar, Anjali (CERN, CH-1211 Geneva 23, Switzerland) ; Berbalk, Justus (CERN, CH-1211 Geneva 23, Switzerland, KU Leuven, Leuven, Belgium) ; Chrysalidis, Katerina (CERN, CH-1211 Geneva 23, Switzerland) ; Frank, Isabel (CERN, CH-1211 Geneva 23, Switzerland) ; Giesel, Paul Florian (CERN, CH-1211 Geneva 23, Switzerland, Universität Greifswald, Greifswald, Germany) ; Grasser, Matthias Alexander (CERN, CH-1211 Geneva 23, Switzerland) ; Heinke, Reinhard (CERN, CH-1211 Geneva 23, Switzerland, University of Manchester, Manchester, UK) ; Kalnina, Patricija (CERN, CH-1211 Geneva 23, Switzerland, Latvijas Universitāte, Rīga, Latvia) et al.
CERN-INTC-2025-003 ; INTC-I-282.
-
2025 - mult..
Full text
|
|
|
2.
|
Upgrade of the PS booster-to-ISOLDE beam transfer line to facilitate an increase in proton driver energy
/ Fraser, Matthew (CERN) ; Bernardes, Ana (CERN) ; Newborough, Antony (CERN) ; del Alamo, Daniel (CERN) ; Grenier-Boley, Edouard (CERN) ; Pozzi, Fabio (CERN) ; Di Giovanni, Gian Piero (CERN) ; Corso, Jean-Pierre (CERN) ; Vollaire, Joachim (CERN) ; Ferreira Somoza, Jose (CERN) et al.
Following the successful completion of the LHC Injectors Upgrade (LIU) project, since 2021 the Proton Synchrotron (PS) Booster has served the LHC injector chain with protons at an increased kinetic energy of 2 GeV. An upgrade of the ISOLDE (Isotope Separator On-Line DEvice) facility has long been considered to produce radioactive ion beams with a higher energy proton driver beam. [...]
2024 - 4 p.
- Published in : JACoW IPAC 2024 (2024) THPR28
Fulltext: PDF;
In : 15th International Particle Accelerator Conference (IPAC 2024), Nashville, TN, United States, 19 - 24 May 2024, pp.THPR28
|
|
|
3.
|
CERN-MEDICIS: Operational indicators to support the production of new medical radionuclides by mass-separation
/ Stora, T (CERN) ; Duchemin, C (CERN) ; Andreazza, W (CERN) ; Aubert, E (CERN) ; Bernerd, C (CERN ; Leuven U.) ; Cocolios, T (Leuven U.) ; Deschamps, M (CERN) ; Dorsival, A (CERN) ; Duraffourg, M (CERN) ; Fedosseev, V (CERN) et al.
CERN-MEDICIS is an isotope mass separation facility for biomedical R&D; located in a class A laboratory, receiving up to 50% of the 1.4GeV PSB protons. It was commissioned with radioactive ion beams in 2017. [...]
2023 - 6 p.
- Published in : J. Phys. : Conf. Ser.: 2687 (2024) , no. 8, pp. 082039
- Published in : JACoW IPAC: 2023 (2023) , pp. WEPM125
Fulltext: PublicationJACoW - PDF; PublicationIOP - PDF;
In : 14th International Particle Accelerator Conference (IPAC 2023), Venice, Italy, 7 - 12 May 2023, pp.082039
|
|
|
4.
|
Commissioning of the RFQcb at the Isolde Offline 2 target test facility
/ Schuett, M (CERN) ; Rothe, S (CERN) ; Au, M (CERN ; Mainz U.) ; Koliatos, A (CERN) ; Bissell, M (CERN) ; Bidault, N (CERN) ; Le, L (CERN) ; Boucherie, A (CERN) ; Heinke, R (CERN) ; Chrysalidis, K (CERN) et al.
The Offline 2 mass separator laboratory is part of the CERN-ISOLDE Offline facilities - a suite of installations required to perform essential quality control on target and ion source units before irradiation at CERN-ISOLDE. The facility is also used for offline studies as a prerequisite before conducting any beam development on-line, especially establishing systematic effects. [...]
2023
- Published in : JACoW IPAC 2023 (2023) TUPA081
Fulltext: PDF;
In : 14th International Particle Accelerator Conference (IPAC 2023), Venice, Italy, 7 - 12 May 2023, pp.TUPA081
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
CERN-MEDICIS: A Review Since Commissioning in 2017
/ MEDICIS Collaboration
The CERN-MEDICIS (MEDical Isotopes Collected from ISolde) facility has delivered its first radioactive ion beam at CERN (Switzerland) in December 2017 to support the research and development in nuclear medicine using non-conventional radionuclides. Since then, fourteen institutes, including CERN, have joined the collaboration to drive the scientific program of this unique installation and evaluate the needs of the community to improve the research in imaging, diagnostics, radiation therapy and personalized medicine. [...]
2021 - 11 p.
- Published in : Frontiers in Medicine 8 (2021) 693682
Fulltext: PDF;
|
|
|
8.
|
CERN-MEDICIS: A Unique Facility for the Production of Non-Conventional Radionuclides for the Medical Research
/ Duchemin, Charlotte (CERN) ; Barbero-Soto, Esther (CERN) ; Bernardes, Ana (CERN) ; Catherall, Richard (CERN) ; Chevallay, Eric (CERN) ; Cocolios, Thomas (Leuven U.) ; Dorsival, Alexandre (CERN) ; Fedosseev, Valentin (CERN) ; Fernier, Pascal (CERN) ; Gilardoni, Simone (CERN) et al.
The MEDICIS facility is a unique facility located at CERN dedicated to the production of non-conventional radionuclides for research and development in imaging, diagnostics and radiation therapy. It exploits in a Class A work sector, a dedicated isotope separator beam line, a target irradiation station at the 1.4 GeV Proton Synchroton Booster (PSB) and receives activated targets from external institutes during CERN Long Shut-Downs. [...]
CERN-ACC-2021-010.-
2021 - 5 p.
- Published in : JACoW IPAC 2020 (2020) THVIR13
Fulltext: PDF;
In : 11th International Particle Accelerator Conference, Caen, France, 10 - 15 May 2020, pp.THVIR13
|
|
|
9.
|
|
Linac4 design report
/ Vretenar, Maurizio (ed.)
Linear accelerator 4 (Linac4) is designed to accelerate negative hydrogen ions for injection into the Proton Synchrotron Booster (PSB) [...]
CERN-2020-006.
-
Geneva : CERN, 2020. - 137 p.
(CERN Yellow Reports: Monographs ; 6/2020)
|
ebook
|
|
10.
|
Quantification of radioisotopes produced in 1.4 GeV proton irradiated lead–bismuth eutectic targets
/ Choudhury, Dibyasree (Saha Inst.) ; Lahiri, Susanta (Saha Inst. ; HBNI, Mumbai) ; Naskar, Nabanita (Saha Inst.) ; Delonca, Melanie (CERN) ; Stora, Thierry (CERN) ; Ramos, Joao Pedro (CERN ; SCK-CEN, Mol) ; Aubert, Elodie (CERN) ; Dorsival, Alexandre (CERN) ; Vollaire, Joachim (CERN) ; Augusto, Ricardo (CERN ; Munich U. ; TRIUMF) et al.
Six cylindrical lead bismuth eutectic (LBE) targets having fixed diameter of 6 mm and varying lengths of 8–50 mm were irradiated with a 1.4 GeV proton beam at CERN-ISOLDE. Both short-lived ($5\hbox { h } {<}\hbox {T}_{1/2} {<}5\hbox { days}$) and long-lived ($\hbox {T}_{1/2} {>}5\hbox { days}$) radionuclides were identified by off-line $\gamma $-spectrometry and their activities at the end of bombardment (EOB) were determined. [...]
2020 - 15 p.
- Published in : Eur. Phys. J. A 56 (2020) 204
|
|
epost-alarm
eller starta en prenumeration på 
RSS-strömmen.